α-Fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) in prognosis of hepatocellular carcinoma after radiofrequency

α-Fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) in prognosis of hepatocellular carcinoma after radiofrequency

Abstract Background Numerous hepatocellular carcinoma (HCC) biomarkers have been assessed in the diagnosis and prognosis of HCC. The aim of this study was to assess the value of α-fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) as prognostic markers in hepatocellular carcinoma after...

Full description

Bibliographic Details
Main Authors: Ahmed Shawky Elsawabi, Khaled Abdel wahab, Wesam Ibrahim, Shereen Saleh, Yasmine Massoud, Mohamed Abdelbary, Ahmed Nabih
Format: Article
Language:English
Published: SpringerOpen 2019-12-01
Series:Egyptian Liver Journal
Subjects:
Hepatocellular carcinoma (HCC)
α-Fetoprotein (AFP)
AFP-L3%
Transforming growth factor B1 (TGFB1)
Online Access:https://doi.org/10.1186/s43066-019-0008-5

Internet

https://doi.org/10.1186/s43066-019-0008-5

Similar Items